COOPER, Dan; MOISAN, Jocelyne; ABDOUS, Belkacem; GRÉGOIRE, Jean-Pierre. A POPULATION-BASED COST-EFFECTIVENESS ANALYSIS OF OLANZAPINE AND RISPERIDONE AMONG AMBULATORY PATIENTS WITH SCHIZOPHRENIA. Journal of Population Therapeutics and Clinical Pharmacology, [S. l.], v. 15, n. 3, 2018. Disponível em: https://mail.jptcp.com/index.php/jptcp/article/view/229. Acesso em: 19 nov. 2024.